Skip to content

A key technique for the treatment of small and medium-sized benign prostatic hyperplasia by laser removal research and promotion of standardized hierarchical diagnosis and treatment processes

A key technique for the treatment of small and medium-sized benign prostatic hyperplasia by laser removal research and promotion of standardized hierarchical diagnosis and treatment processes

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200057256
Enrollment
Unknown
Registered
2022-03-05
Start date
2022-03-16
Completion date
Unknown
Last updated
2023-10-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

benign prostatic hyperplasia

Interventions

Control group 1:Transurethral resection of the prostate
Control group 2:Routine transurethral holmium laser enucleation of the prostate
Experimental group:Holmium laser enucleation of the prostate with 12 points of urethral mucosa preserved

Sponsors

Shanghai Jiao Tong University Affiliated Sixth People’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1. Benign prostatic hyperplasia with a prostate volume of 30-60 mL; 2. Moderate-severe lower urinary tract symptoms (IPSS >= 12) that have significantly affected quality of life, especially poor medication or refusal of medication; 3. Maximum urinary flow rate < 15 mL/s; 4. Complicated with bladder stones, recurrent hematuria, recurrent urinary tract infection, more than 2 times of urinary retention, upper urinary tract hydronephrosis, etc.

Exclusion criteria

Exclusion criteria: The patients were accompanied by neurogenic bladder, overactive bladder, prostate cancer, bladder detrusor muscle weakness.

Design outcomes

Primary

MeasureTime frame
operation methods;intraoperative and postoperative information;postoperative complications;

Secondary

MeasureTime frame
general information;

Countries

China

Contacts

Public ContactQiang Fu

Shanghai Jiao Tong University Affiliated Sixth People’s Hospital

jamesqfu@aliyun.com+86 13501834727

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026